You have to be signed in to use this resource.
Overview of Immune-Related Adverse Events
Certificate available: complete this course to be awarded a certificate
This module aims to enable learners to describe the difference between chemotherapy and immune checkpoint inhibitor (ICI) toxicities , identify when immune related adverse events (irAEs) are most likely to occur, choose the correct resources to grade irAEs, and evaluate standard blood results associated with ICIs.
Resource details
| Contributed by: | Immunotherapy |
| Authored by: |
|
| Licence: | © All rights reserved More information on licences |
| Last updated: | 18 July 2024 |
| First contributed: | 11 July 2024 |
| Audience access level: | General user |
Share this resource
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.